Search

everythinglearnresearchcommunity

for

Search:↓

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Type 3C diabetes is a distinct condition needing more research and treatment strategies.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

PDCD4 is important for controlling skin cell growth and healing.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Treg cells help repair and regenerate tissues by interacting with local cells.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.